Loading...
Inflation Reduction Act And Biosimilars Will Undermine Pricing Power
AnalystLowTarget's Fair Value
US$5.35
4.1% overvalued intrinsic discount01 Sep
US$5.57
1Y
9.0%7D
1.3%1Y
9.0%7D
1.3%Edit anytime before Sep 1 10:19 PM. Then post Updates to your followers.